Clinical Research Directory
Browse clinical research sites, groups, and studies.
Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus
Sponsor: Imperial College London
Summary
The aim of this study is to investigate the continued usage of standard diabetes medications in the post operative period following bariatric surgery to determine whether this approach may improve long term diabetes control. At present, the standard of treatment in patients with type 2 diabetes is that all medication is stopped in the immediate postoperative period and only re-started if symptoms of diabetes re-emerge. Although a large proportion of patients with diabetes will initially go in to remission, 80% experience relapse within five years. This study is needed to determine whether continuing medications is not only safe but will improve long term outcomes for patients with diabetes.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2021-04-01
Completion Date
2027-08-01
Last Updated
2022-08-08
Healthy Volunteers
No
Conditions
Interventions
Bariatric surgery + goal directed medical therapy
Patients will undergo bariatric surgery (RYGB or SG) with goal directed medical therapy titrated to specific end points for BP, HbA1c and lipids
Bariatric surgery
Patients will undergo bariatric surgery (RYGB or SG) with usual care for diabetes mellitus undertaken by their primary care provider/general practitioner
Locations (1)
University College Dublin
Dublin, Ireland